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Abstract. Sengers syndrome is a rare autosomal recessive mitochondrial disease characterized by lactic acidosis, hypertrophic
cardiomyopathy and bilateral cataracts. We present here a case of neonatal demise, within the first day of life, who initially
presented with severe lactic acidosis, with evidence of both chorioamnionitis and cardiogenic shock. Initial metabolic labs
demonstrated a severe lactic acidosis prompting genetic testing which revealed a homozygous pathogenic variant for Sengers
syndrome in AGK, c.979A > T; p.K327∗. In addition to the canonical features of Sengers syndrome, our patient is the first
reported case with liver dysfunction extending the phenotypic spectrum both in terms of severity and complications. This
case also highlights the importance of maintaining a broad differential for congenital lactic acidosis.
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1. Introduction
Sengers syndrome was first identified in 1975 by the co-occurrence of the near pathognomonic
triad of congenital cataracts, lactic acidosis and cardiomyopathy [1]. This disorder was subsequently
shown to be caused by recessively inherited mitochondrial dysfunction and was noted to present
in two distinct forms: a severe neonatal and more insidious later onset presentation [2, 3]. Sengers
syndrome is caused by loss of function variants in AGK, the gene encoding acylglycerol kinase [4].
Acylglycerol kinase is a mitochondrial transmembrane enzyme that catalyzes the phosphorylation of
monoacylglycerol and diacylglycerol to lysophosphatidic and phosphatidic acid, which are important
secondary messengers and regulate mitochondrial ultrastructure. AGK was recently identified as a
component of the mitochondrial TIM22 complex, and is essential for import and assembly of metabolite
carrier proteins in a kinase-independent manner [5]. These kinase dependent and independent findings
have helped elucidate the multiple functions of AGK, explaining the diverse metabolic findings present
in Sengers syndrome.
To date there have been less than thirty molecularly diagnosed patients with Sengers syndrome,
with the majority of these consisting of later onset disease as opposed to the neonatal form [3]. These
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distinct presentations differ in that neonatal forms are noted to have central nervous system involvement
including cerebellar hypoplasia while adult onset forms are more likely to have pathogenic variants
secondary to splicing defects suggesting possible low level gene expression [6]. We report here a case
of neonatal demise within the first day of life, presenting with severe lactic acidosis and systemic
hypotension, in the setting of both chorioamnionitis and cardiomyopathy, found to have Sengers
syndrome.
2. Materials and methods
A CMA SNP array (CytoScan® Dx) was performed showing areas of homozygosity over 5.8% of
the array. Candidate genes within the areas of homozygosity were reviewed. A nuclear mitochondrial
panel of 35 genes was done by Massively Paralleled Sequencing using TruSight One kit (v1.0). Plasma
amino acids were run on a Biochrom 30 Amino Acid Analyzer.
3. Case presentation
Our case is a 1-day-old full term boy born from a G1P0 31-year-old mother who had an uneventful
pregnancy receiving routine prenatal care. He was the product of Iranian consanguineous parents,
known to be second cousins, with reported history of infertility prior to this naturally conceived
pregnancy. Rupture of membranes occurred 40 hours prior to delivery and meconium stained fluid
was present. During labor, maternal fever was noted, and maternal administration of broad-spectrum
antibiotics were started for clinically diagnosed chorioamnionitis. At birth, the newborn showed a
weak cry and decreased tone. He was found to be tachycardic and febrile with APGAR scores of 7 and
8 and was started on broad spectrum antibiotics for presumed sepsis. Physical exam was notable for
bilateral opacification of the corneas and hypospadias. At 5 hours of life, he began to have progressive
encephalopathy and respiratory distress resulting in intubation. Initial laboratory findings were notable
for a severe metabolic acidosis with insufficient respiratory compensation (pH = 6.94, pCO2 = 22.8,
HCO3 = 6, Anion Gap = 49, Lactate of 354.6 mg/dl). Fluid resuscitation with normal saline and admin-
istration of intravenous sodium bicarbonate resulted in minimal improvement in acidosis. The infant
became progressively hypotensive, despite initiation of continuous vasopressor infusion. A chest X-ray
was notable for cardiomegaly and an echocardiogram revealed severe biventricular dysfunction and
ventricular trabeculations suggestive of cardiomyopathy (Fig. 1A). Further studies showed evidence of
synthetic liver dysfunction including low albumin, total protein, and fibrinogen, and prolonged PT, PTT
with normal bilirubin and elevated transaminases. Hematologic labs were significant for leukocytosis
with a predominance of immature bands, anemia, and thrombocytopenia which in combination with
coagulation studies were concerning for disseminated intravascular coagulation. Bacterial cultures of
blood, urine and cerebrospinal fluid were drawn and ultimately resulted as normal studies. Imaging
included a head ultrasound showing “slit-like” lateral ventricles, decreased size of the extra-axial
spaces and crowded posterior cranial fossa, suggestive of generalized brain edema. Abdominal ultra-
sound showed an edematous liver with increased periportal echogenicity, but no evidence of hepatitis.
Initially, the combined clinical and laboratory findings were suggestive of both cardiogenic and septic
shock. However, the degree of lactic acidosis seemed excessive relative to the infant’s hemodynamic
status and was refractory to resuscitation, prompting a more detailed metabolic evaluation.
Serum lactate was elevated at 354.6 mg/dl, pyruvic acid 3.81 mg/dL, and the lactate to pyruvate ratio
was 91, suggestive of mitochondrial disease. Additional genetic and metabolic testing included chro-
mosomal microarray and plasma amino acids. Results from a nuclear mitochondrial gene panel revealed
a homozygous pathogenic variant in AGK, c.979A > T p.K327∗. This same genotype was present in a
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Fig. 1. A) Portable CXR showing marked cardiomegaly. B) Plasma amino acid levels represented as ratio of the upper limit
of normal. Dashed line is present at the upper level of normal, equal to one, with amino acids with asterisk denoting values
more than double.
large consanguineous family with multiple neonatal Sengers syndrome cases [7, 8]. Plasma amino acid
analysis revealed elevation of alanine, methionine, phenylalanine, and branched chain amino acids,
indicating liver dysfunction and catabolism (Fig. 1B). These elevations were also consistent with in
vitro experiments where loss of AGK leads to an accumulation of TCA cycle intermediates [5]. Despite
aggressive medical management, the patient had a cardiac arrest likely due to worsening cardiac func-
tion secondary to refractory metabolic acidosis and multi-organ system dysfunction, dying on day of
life one. An autopsy was declined per the family’s request.
The clinical course and genetic tests suggest that this infant had severe manifestation of Sengers
syndrome, that may have been exacerbated by clinical chorioamnionitis and culture-negative sepsis.
Although testing was unable to provide a diagnosis prior to our patient’s death, it allowed the family
the option for pre-implantation genetic testing for future pregnancies.
4. Conclusions
To our knowledge, we present the most severe case of Sengers syndrome reported to date. A novel
finding in our patient was clinically-apparent synthetic liver dysfunction. While elevated transaminases
and prolonged coagulation studies can result from septic shock, and/or disseminated intravascular
coagulation, ultimately, infectious studies were negative. Rather, this may represent an additional
manifestation of Sengers syndrome. Although a single patient is reported in the literature with primary
liver involvement, characterized as cytosolic granules in liver cells found on autopsy, none has had
clinically-evident liver impairment [8].
Alternatively, this patient may have had another autosomal recessive condition that could explain
his synthetic liver dysfunction, especially considering the multiple areas of homozygosity noted by
CMA; however, given the acute situation and rapid demise, whole exome sequencing was not able to
be performed.
This case highlights the importance of maintaining a wide differential diagnosis for congenital lactic
acidosis despite seemingly obvious etiologies [9]. This is particularly striking in our case given the
evidence for septic and cardiogenic shock, yet these etiologies were unlikely to be the sole underly-
ing cause of such profound, and disproportionate metabolic decompensation. Finally, despite recent
advances in our understanding of AGK function, the phenotypic diversity attributed to other genes
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involved in the TIM22 complex, such as DDP1 in Mohr-Tranebjaerg Syndrome, suggest multiple
mechanisms of action that may be better elucidated through further detailed genotype-phenotype
correlations [10].
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